Q2 sales declined 1% year-over-year with EBIT margin dropping to 7.2%, while H1 sales grew 29%. Cost-saving measures and two acquisitions were implemented to address weak sales and margin pressure.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.